An Vandebosch

An Vandebosch serves as Head of Development at argenx, where she leads Development Strategy and Execution across the pipeline. She joined argenx in 2023 as Head of Quantitative Sciences, bringing deep expertise in clinical development and data‑driven decision‑making.

Before joining argenx, An spent almost 18 years at Johnson & Johnson, taking on roles of increasing responsibility across multiple disease areas. She made significant contributions to numerous clinical development programs, including serving as Statistics and Modeling Lead for the COVID‑19 vaccine program. An is passionate about innovation and has been highly active within the broader biopharma statistics community.